Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 3Febrile Neutropenia 3Prostatic Neoplasms 2Neutropenia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pancreatic Cyst 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Infections 1Hematologic Neoplasms 1Early Stage Breast Cancer 1Cysts 1Cystectomy 1Breast Neoplasms 1

Interventions

Filgrastim 2Ciprofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Early Stage Breast Cancer × Ciprofloxacin × Clear all
NCT02816112 2020-05-27

REaCT-TC2

Ottawa Hospital Research Institute

Phase 4 Completed
458 enrolled
Breast

Early Stage Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡